Here’s the Reason Why Capricor Therapeutics, Inc. (CAPR) Stock is Roaring in the Premarket
Maria Masood
January 25, 2022
Capricor Therapeutics, Inc. (CAPR) is a biopharmaceutical company engaged in the development of therapeutics for treating an array of diseases. The company’s pipeline product candidate